An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
Active, not recruiting
Bristol-Myers Squibb
Phase 1/Phase 2
The purpose of the study is to determine safety and effectiveness of experimental medication
BMS-986205 when combined with Nivolumab and in combination with both Nivolumab and Ipilimumab
in patients with cancers that are advanced or have spread. Pharmacokinetics and
pharmacodynamics of BMS-986205 when combined with Nivolumab and in combination with Nivolumab
and Ipilimumab in this patient population will also be assessed.
An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer
Terminated
Bristol-Myers Squibb
Phase 2
The purpose of this study is to determine whether Nivolumab, in combination with other
therapies, is effective in patients with advanced Non-Small Cell lung cancer
A Study to Test Combination Treatments in Patients With Advanced Gastric Cancer
Active, not recruiting
Clovis Oncology, Inc.
Phase 2
The purpose of this study is to determine whether Nivolumab in combination with other
therapies is more effective than Nivolumab in combination with Ipilimumab in treating
patients/subjects with advanced gastric cancer.
A Study to Test Combination Treatments in Patients With Advanced Gastric Cancer
Active, not recruiting
Bristol-Myers Squibb
Phase 2
The purpose of this study is to determine whether Nivolumab in combination with other
therapies is more effective than Nivolumab in combination with Ipilimumab in treating
patients/subjects with advanced gastric cancer.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
